Nanhua Current Deferred Revenue from 2010 to 2024
| 000504 Stock | 9.66 0.16 1.63% |
Check Nanhua Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanhua Bio's main balance sheet or income statement drivers, such as Interest Expense of 10.7 M, Selling General Administrative of 43 M or Total Revenue of 117.7 M, as well as many indicators such as . Nanhua financial statements analysis is a perfect complement when working with Nanhua Bio Valuation or Volatility modules.
Nanhua | Current Deferred Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nanhua Stock
Nanhua Bio financial ratios help investors to determine whether Nanhua Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanhua with respect to the benefits of owning Nanhua Bio security.